Traders eyes are on ppch following a tremendous move the
Traders eyes are on ppch following a tremendous move the past week with eye-popping volume and price movement. There was absolutely no reason for the selloff of the stock over the past 6 months other than some profit taking with a huge dose of manipulation to drive the pps down to rediculous levels where we have seen massive accumulation. I believe this has been carefully orchestrated by some group of traders. When they drove the pps through the roof one year ago, there was not much substance to the move other than speculation. That however has now changed. PPCH is not setting upon a sufficient bank account to advance current studies to Phase I scheduled to be initiated in either the 3rd or 4th quarter. Mngt has a meeting now planned with the EU regulatory agency, and research is being conducted now in the US in preperation for FDA meetings some time likely in the 2nd or 3rd quarter. Traders are well aware of the immense potential for PRP as demonstrated in both stem cell research, as well as pancreatic and colorectal cancer. The fact that it has been shown to hinder and perhaps halt metastisis in utterly incredible.
This trading goup now has sufficient holding it appears they are ready to drive the pps north as Phase I and positive studies have now proven that PPCH could be on the verge of a breakthrough treatment for cancer. Fasten your seat belts people!
2
Propanc Biopharma, Inc. (PPCB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Ensurge Micropower ASA Expands Share Capital for Future Development Recently, Ensurge Micropower ASA made a significant announcement regarding a successful private placement of shares that was fully underwritten. This move is a key step in enhancing the company's financial foundation and preparing for future growth. Successful Registration of Share Capital Increase The...
Continue Reading
Understanding the Investigation Against Power Solutions International Power Solutions International, Inc. (NASDAQ: PSIX), known for its innovative power generation solutions, is currently facing an investigation related to possible violations of federal securities laws. This inquiry has been initiated to protect investors who may have suffered financial losses due to the...
Continue Reading
Market Poised for Rapid Growth Surfs up for the point-of-care testing (POCT) market, as fresh numbers just dropped and they're flashy, aiming for a jump from $42 billion in 2025 to nearly $64.8 billion by 2031. That’s a solid 7.5% CAGR for anyone counting. These days, quick-and-dirty diagnostics are what folks in the medical field are pinning their hopes on to keep pace...
Continue Reading
Market Movements of First Solar Recent trading activity has shown significant movements in the options market for First Solar (NASDAQ: FSLR). Financial institutions and traders alike have exhibited clear bearish sentiments this quarter. Our evaluation of recent options data indicates that there were 21 unusual trades for First Solar in recent sessions. Analysis of Trader...
Continue Reading
Overview of Bloomin' Brands, Inc. Bloomin’ Brands, Inc. (NASDAQ: BLMN), a leader in the casual dining sector, is currently navigating turbulent waters as its stock experiences a significant downturn. The company's shares have recently dropped substantially, reflecting concerns over profitability amidst rising operating expenses. Strong Earnings Yet Declining Margins In...
Continue Reading
